[ad_1]
Our country is waiting for a vaccine against Sars-Cov-2 on a list from the European Commission.
Until it is ready, we must prepare for everything that involves an immunization campaign with a new vaccine.
And that is because, from the first information, it has to be transported, stored and even managed under very, very special conditions.
Romania has exceeded 113,000 cases of COVID 19, and 808 of them have been detected in the last 24 hours, in a series of 6,348 tests.
Basically, X-rays from the last few weeks show that the daily average has increased from 1,200 to almost 1,500 cases.
But the list of people infected with SARS-VOC-2 is growing more and more in other European countries. And in this context, interest in buying a vaccine remains extremely high around the world.
The European Commission has entered into previous contracts with companies that are currently developing this vaccine.
Romania is also on the list of countries where it will be distributed. Our authorities have requested the immunizing serum for 10.7 million people considered at high risk of disease, biological or occupational.
However, before the vaccine is ready, all the necessary preparations must be made in the country so that the vaccination campaign runs smoothly.
Currently, nine prototype vaccines against SARS-VOC-2 are in the final stages of clinical trials, and seven of them require two doses at a time.
Some will require special transport and storage conditions, with temperature being a key factor.
Prof. Dr. Alexandru Rafila, member of the WHO executive committee: “Those based on RNA are transported at -70 – -80 degrees, a temperature difficult to maintain, they will come in special containers that contain carbon dioxide ice. I think we should brag less and prepare for the moment when it will come, specifically, who are responsible, where are the centers, who will receive it, we must inform the people … “
Specifically, health experts say, special vaccination centers should be organized throughout the country.
Prof. Dr. Alexandru Rafila, member of the WHO executive committee: “This vaccine will not be able to be stored, it will probably have to be administered as it arrives. It will be difficult to distribute to 11,000 family doctors, you have to think of a strategy, some centers … ”
The representatives of the Ministry of Health say that they take into account all these conditions.
Andrei Baciu, Secretary of State of the Ministry of Health: “We look at what we have and what we need, what we lack, there are certain shortcomings, we are talking about the cold chain and operations … here we have to improve.”
On the other hand, if one or more anti-Covid vaccines receive regulatory approval, up to two billion doses could be produced early next year, say experts who have assessed global production capacity.
Analyzes show that only one in 10 people was able to get immunized in the first year after the arrival of coronavirus vaccines.
